News

Filter

AstraZeneca stresses confidence in independence, highlighting strong R&D pipeline

15-05-2014

Anglo-Swedish pharma major AstraZeneca, the subject of the controversial takeover attempt by Pfizer,…

AstraZenecaCardio-vascularMergers & AcquisitionsMetabolicsOncologyPharmaceuticalResearchRespiratory and Pulmonary

MedImmune joins research collaboration with the University of California

MedImmune joins research collaboration with the University of California

17-02-2014

MedImmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca,…

Antibiotics and Infectious diseasesCardio-vascularInflammatory diseasesMedImmuneMetabolicsNeurologicalOncologyPharmaceuticalResearchRespiratory and PulmonaryUSA

B-MS ties knot with Duke University on R&D

29-02-2012

Bristol-Myers Squibb has forged a partnership with Duke University in the USA that will see the academic…

Bristol-Myers SquibbCardio-vascularGeneralHomeLysophosphatidic acid 1 (LPA1)MetabolicsOncologyPfizerPharmaceuticalRespiratory and PulmonarySanofi

Boehringer Ingelheim in $60 million upfront deal with MacroGenics for DART-based antibody therapeutics

27-10-2010

Family-owned German drug major Boehringer Ingelheim has entered into a global alliance with privately-held…

Boehringer IngelheimImmunologicalsLicensingMacroGenicsMetabolicsOncologyPharmaceuticalResearchRespiratory and Pulmonary

COMPANY SPOTLIGHT

Menarini

Back to top